Cite
HARVARD Citation
Storgaard, H. et al. (2016). Diabetic Ketoacidosis in a Patient with Type 2 Diabetes After Initiation of Sodium–Glucose Cotransporter 2 Inhibitor Treatment. Basic & clinical pharmacology & toxicology. 118 (2), pp. 168-170. [Online].